JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 9, 2008; DOI: 10.1124/jpet.108.147330


0022-3565/09/3283-715-722$20.00
JPET 328:715-722, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.108.147330v1
328/3/715    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tierno, M. B.
Right arrow Articles by Lazo, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tierno, M. B.
Right arrow Articles by Lazo, J. S.

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

Microtubule Binding and Disruption and Induction of Premature Senescence by Disorazole C1Formula

Marni Brisson Tierno, Carolyn A. Kitchens, Bethany Petrik, Thomas H. Graham, Peter Wipf, Fengfeng L. Xu, William S. Saunders, Brianne S. Raccor, Raghavan Balachandran, Billy W. Day, Jane R. Stout, Claire E. Walczak, Alexander P. Ducruet, Celeste E. Reese, and John S. Lazo

Drug Discovery Institute (M.B.T., C.A.K., B.P., P.W., B.W.D., A.P.D., C.E.R., J.S.L.), Departments of Pharmacology and Chemical Biology (M.B.T., C.A.K., A.P.D., J.S.L.), Chemistry (T.H.G., P.W.), Biological Sciences (F.L.X., W.S.S.), and Pharmaceutical Sciences (B.S.R., R.B., B.W.D.), and Center for Chemical Methodologies and Library Development (P.W.), University of Pittsburgh, Pittsburgh, Pennsylvania; and Medical Sciences Program, Indiana University, Bloomington, Indiana (J.R.S., C.E.W.)

Disorazoles comprise a family of 29 macrocyclic polyketides isolated from the fermentation broth of the myxobacterium Sorangium cellulosum. The major fermentation product, disorazole A1, was found previously to irreversibly bind to tubulin and to have potent cytotoxic activity against tumor cells, possibly because of its highly electrophilic epoxide moiety. To test this hypothesis, we synthesized the epoxide-free disorazole C1 and found it retained potent antiproliferative activity against tumor cells, causing prominent G2/M phase arrest and inhibition of in vitro tubulin polymerization. Furthermore, disorazole C1 produced disorganized microtubules at interphase, misaligned chromosomes during mitosis, apoptosis, and premature senescence in the surviving cell populations. Using a tubulin polymerization assay, we found disorazole C1 inhibited purified bovine tubulin polymerization, with an IC50 of 11.8 ± 0.4 µM, and inhibited [3H]vinblastine binding noncompetitively, with a Ki of 4.5 ± 0.6 µM. We also found noncompetitive inhibition of [3H]dolastatin 10 binding by disorazole C1, with a Ki of 10.6 ± 1.5 µM, indicating that disorazole C1 bound tubulin uniquely among known antimitotic agents. Disorazole C1 could be a valuable chemical probe for studying the process of mitotic spindle disruption and its relationship to premature senescence.


Received for publication October 10, 2008
Accepted December 8, 2008.

Address correspondence to: John S. Lazo, Department of Pharmacology and Chemical Biology, University of Pittsburgh Drug Discovery Institute, Biomedical Science Tower 3, Suite 10040, 3401 Fifth Avenue, University of Pittsburgh, Pittsburgh, PA 15260. E-mail: lazo{at}pitt.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics.